
Health & Science
FDA authorizes 1st antiviral pill for COVID
Posted on · In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.
Posted on · In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.
Posted on · In the U.S., the Pfizer vaccine is the only option for children and teenagers.
Posted on · The FDA on Friday granted emergency use authorization for the Pfizer-BioNTech and Moderna booster shots. The boosters have already been available for people 65 and older and to high-risk adults.
Posted on · Some vaccine providers were ready to begin administering the booster shot as early as Friday.
Posted on · A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.
Posted on · Advisers to the Food and Drug Administration voted against approval of a booster of the Pfizer-BioNTech COVID-19 vaccine for people 16 years and older. They later supported boosters for older people.
Posted on · "To defend this Nation, we need a healthy and ready force," Defense Secretary Lloyd Austin said in a memo to employees Monday.
Posted on · According to Harris County Public Health, children 12-15 can now receive the Pfizer COVID-19 vaccine at NRG Park.
Posted on · The White House has been urging family doctors to encourage vaccination of adolescents and the CDC director said "providers may begin vaccinating them right away."
Posted on · The company said in late March that clinical trials showed the vaccine elicits "100% efficacy and robust antibody responses" in adolescents.
Posted on · The Food and Drug Administration typically follows the advice of its expert advisers. A quick agency decision on the Johnson & Johnson vaccine is expected given the state of the pandemic.
Posted on · Whether or not food is safe after an electrical outage can depend on a number of factors.
Posted on · In a 17-4 vote, an expert committee concluded that the scientific evidence supports the authorization of the COVID-19 vaccine from Pfizer and BioNTech for emergency use during the pandemic.
Posted on · The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.
Posted on · With a vaccine on the horizon, local officials are asking Houstonians to remain vigilant with social distancing and mask wearing, to help stop the spread of COVID-19.